Navigation Links
Genome Engineering Market to Reach US$7.21 bn by 2023, North America Held Dominant Share of 51.0% in 2014: Transparency Market Research
Date:2/18/2016

ALBANY, New York, February 18, 2016 /PRNewswire/ --

A new market research report has been recently published by Transparency Market Research (TMR), a U.S.-based market research and intelligence firm. According to the research study, the Genome Engineering Market was valued at US$2.20 bn in 2014 and is projected to expand at a CAGR of 14.2% from 2015 to 2023.

Genome engineering refers to the strategies and techniques implemented for the modification of target genetic information of any living organism. During the last few years, research spending has increased in gene editing technologies covering number of patents and research papers published exponentially. Synthetic biology received funding of US$ 430 Mn in the U.S. from 2005 to 2010, which was much higher than US$ 160 Mn in Europe during the same period. About 4% and 2% funding was spent on exploring ethical, social, and legal implications (ELSI) of synthetic biology in the U.S. and Europe, respectively.

Avail a Sample Research Study on Genome Engineering Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4671

Genome engineering technologies include Clustered regularly-interspaced short palindromic repeats (CRISPR), Transcription activator-like effector nuclease (TALEN), Zinc finger nuclease (ZFN) and other technologies, while the other technologies include antisense technology and recombinant AAV mediated genome engineering. Of these, CRISPR held the majority share of the market in 2014, followed by TALEN. CRISPR has been identified as the fastest growing segment during the forecast period, as it is cost-effective with high precision. CRISPR method is used for wide variety of disorders like sickle-cell anemia, HIV/AIDS, hemophilia and several forms of cancers. These techniques are in different stages of clinical development with a focus on modifying the genetic material of somatic cells.

Based on application, the cell line engineering segment accounted major share of the global genome engineering market in terms of revenue. Moreover, the segment is expected to gain market share and emerge as the fastest growing segment during the forecast period. Pharmaceutical and Biotechnology companies segment would grow as a fastest growing end-user segment with major share in the market.

Browse Report: http://www.transparencymarketresearch.com/genome-editing-engineering-market.html

High Demand from Pharmaceutical and Biotechnology Companies Bolsters Genome Engineering Market 

In terms of end user, the global genome engineering market is segmented into academics, pharmaceutical and biotechnology companies, and clinical research organizations (CRO). Among these, the largest share of the market was held by the pharmaceutical and biotechnology companies in 2014. The academics segment is expected to exhibit the fastest CAGR in the near future.

North America Emerges as Largest Regional Market 

Regionally, the global genome engineering market is spread across Asia Pacific, Europe, North America, and Rest of the World. Among these regions, North America held the largest share of the global genome engineering market in 2014, trailed by Europe. North American countries not only substantially contribute to the funding for genome research, but a majority of the key players are located in the U.S. Asia Pacific has emerged as the third-largest market for genome engineering; however, in the forthcoming years, the region is likely to exhibit the highest CAGR. Increase in funding for academic research spending will also boost the market in the near future.

Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Sangamo Biosciences, Inc., Lonza Group Ltd., Horizon Discovery Group Plc, Integrated DNA Technologies, Inc., Lonza Group Ltd., are the major players operating in the global Genome engineering market.

Browse Research Article: http://www.transparencymarketresearch.com/article/genome-editing-engineering-market.htm

The global Genome Engineering Market is segmented as follows: 

Global Genome Engineering Market, by Technology 

  • Clustered regularly interspaced short palindromic repeats (CRISPR)
  • Transcription activator-like effector nuclease (TALEN)
  • Zinc Finger Nuclease (ZFN)
  • Other Technologies

Global Genome Engineering Market, by Application 

  • Overview
  • Cell Line Engineering
  • Animal Genome Engineering
  • Plant Genome Engineering
  • Other Application

Global Genome Engineering Market, by End-User 

  • Overview
  • Pharmaceutical and Biotechnology Companies
  • Academics
  • Clinical Research Organizations 

Other Trending Reports in Biotechnology: 




About Us:  

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact:

Mr. Sudip.S
90 State Street, Suite 700
Albany, NY 12207
United States.
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Blog: http://www.tmrblog.com/



'/>"/>
SOURCE Transparency Market Research
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
2. Human Longevity, Inc. (HLI) to Offer Oncology Products Including Comprehensive Whole Germline, Tumor Genome and Whole Cancer Exome Products
3. MedGenome to Present on OncoPept - a Point Solution in Cancer Immunotherapy at the Novel Immunotherapeutics Summit 2016
4. Syngenta Chose NRGenes DeNovoMAGICTM to Map 12 Genomes in Only Eight Months
5. Genome-Based Drug Companies in China - Reportlinker Review
6. CDC Enters into Research Collaboration with Edico Genome to Evaluate Performance of DRAGEN Hardware Platform
7. Broad Institute receives approximately $40 million grant from National Heart, Lung and Blood Institute for whole genome sequencing of 20,000 people
8. Veritas Genetics Breaks $1,000 Whole Genome Barrier
9. Edico Genome and HudsonAlpha Collaborate to Develop Fully Automated, High-Speed Genomic Analysis Platform
10. Personal Genome Diagnostics Collaborates On Study Uncovering New Actionable Mutations And Prognostic Predictors In Pancreatic Cancer
11. Multiple Studies at American Urological Association Annual Meeting Highlight Accuracy, Broad Applicability of GenomeDxs Decipher Test for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2019)... ... ... Big Buzz continues to build upon a record year in 2019, significantly increasing ... - which primarily serves the biosciences, specialty clinic and senior living industries - was ... In June, Big Buzz was named a Top Colorado Agency with a 5.0 rating ...
(Date:11/6/2019)... VEGAS (PRWEB) , ... November 06, 2019 , ... ... program focused on sustainable results, today unveiled new research exploring mobile behaviors that ... weight loss program. , Presented at ObesityWeek 2019, the new study, “Mobile ...
(Date:11/5/2019)... SEATTLE (PRWEB) , ... November 05, 2019 , ... Ida ... a skilled nursing facility. This will result in the layoff of 147 full- and ... next 60 days. This transition will enable Ida Culver House Broadview to shift its ...
Breaking Medicine Technology:
(Date:11/11/2019)... ... ... PracticeLink Live! Atlanta Physician Career Fair will take place Thursday, November 14, ... continue until 8:00 p.m. A free, optional seminar for job-seeking physicians, residents and fellows, ... Both the career fair and seminar are open to residents and fellows, as well ...
(Date:11/9/2019)... ... 08, 2019 , ... Mount Sinai Medical-Legal Partnership (MSMLP), an organization formed to ... free special education law and advocacy assistance to families and patients in need. The ... the work of contributions of Blaine (“Fin”) Fogg, who was a member of the ...
(Date:11/7/2019)... ... November 06, 2019 , ... An October 13 article ... United States. According to the article, while no U.S. state had an obesity rate ... over 20 percent obese. The article cites quite a few reasons for this rise, ...
(Date:11/7/2019)... Va. (PRWEB) , ... November 07, 2019 , ... Understanding ... – 3:00 p.m. EST, https://www.fdanews.com/understandudi , Are EU device and IV diagnostics ... to new EU device regulations —UDI — is ahead, and many device and diagnostics ...
(Date:11/6/2019)... ... November 06, 2019 , ... ... label nutritional bar and functional powder solutions, recently achieved FSSC 22000 Certification of ... “We are pleased to share the news that we have achieved FSSC 22000 ...
Breaking Medicine News(10 mins):